IO Biotech shares rise 11.57% after-hours after analyst rating upgrade and $0.10 earnings beat.

martes, 3 de marzo de 2026, 6:02 pm ET1 min de lectura
IOBT--
IO Biotech surged 11.57% in after-hours trading following an investment bank analyst rating update and reporting earnings that beat estimates by $0.10, with revenue in line with forecasts. The positive analyst action and strong earnings performance likely drove the significant after-hours gain.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios